FDA to Host Public Meeting on MDUFA Reauthorization

The U.S. Food and Drug Administration will host a public meeting on August 5, 2026, to discuss proposed recommendations for the reauthorization of the Medical Device User Fee Amendments (MDUFA) for fiscal years 2028 through 2032. This meeting is relevant to medical device manufacturers and HTM professionals.